Plus Three

Plus Three

Plus Three attempts to make sense of the complex connections between drugs, science, capitalism, policy, and culture. The podcast is co-hosted by Psymposia co-founder Brian Normand, psychedelics researcher Nese Devenot, evolutionary ecologist Brian Pace, and underground researcher David Nickles. Subscribe and listen today on Apple Podcasts, Google Play, Spotify, Stitcher, Radio Public, Deezer, RSS, or

Psychedelics, Sex, Power, Silence

In this episode, Lily Kay Ross joins us to discuss Olivia Goldhill’s story, “Psychedelic therapy has a sexual abuse problem.” Ross recently completed her doctorate studying social responses to sexual violence. She brings both her personal experience with sexual violence and poor community responses in psychedelic spaces and her academic insights to bear on the myriad of questions highlighted by Goldhill’s reporting.

Douglas Rushkoff on the Parallels Between Psychedelic and Digital Mainstreaming

Plus Three is joined by author and host of the Team Human podcast, Douglas Rushkoff, to discuss some of the parallel trajectories between psychedelic and digital mainstreaming. Will COVID-19 be to psychedelics as 9/11 was to surveillance capitalism? September 11th became the excuse to implement a surveillance state and surrender digital technologies to corporations. Will we see psychedelic medicines become the go-to recovery option for COVID-related mental health fallout? We also explore what a true psychedelic renaissance might look like.

Dear Psychedelic Researchers

On the one hand, psychedelics hold promise for personal healing and transformative individual change, and when psychedelics are eventually accepted by mainstream medicine, they will likely impact mental health outcomes for the better. But the broken systems highlighted by the coronavirus pandemic offer insight into why mental health has reached epidemic proportions in the first place.

Amidst Pandemic, Psychedelic Investor Christan Angermayer Can’t Imagine Life Beyond Capitalism

As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer

In response to the coronavirus pandemic, Christian Angermayer—the world's largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Dear Psychedelic Researchers

The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Capitalism can’t save us from coronavirus. Neither can psychedelics.

In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the "psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization of a "capitalist animism"—treating social phenomena like markets or financial capital as living entities—that fixates on "economic health" at the expense of public health. As this unprecedented situation continues to unfold, we explore some considerations for this sudden period of social isolation within a broader culture of social alienation.

+ Alan Piper – Strange Nazis

Alan Piper is a maverick historian of ideas with a penchant for unique, deep dives into rich veins of psychedelia. Piper’s 2015 monograph, Strange Drugs Make for Bedfellows: Ernst Jünger, Albert Hofmann, and the Politics of Psychedelics was foundational for the critique explored in Brian Pace’s controversial Lucy in the Sky with Nazis: Psychedelics and the Right Wing. In this interview, Pace interviews Piper about Hofmann tripping buddy and Wehrmacht Captain Jünger, LSD and ideology— clarifying concepts and dispelling myths.

This Is What Psychedelic Mainstreaming Looks Like

It's not the Hokey Pokey, but psychedelic mainstreaming seems to be what it's all about. We explore some of the realities and questions of what it means to take psychedelics "mainstream.”

A Statement Regarding “The Emergence of a New Market: Psychedelic Science Conferences”

Our statement on a recent Chacruna article by Dr. Bia Labate